Bradley A. Maron, MD
Adjunct Instructor
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine

MD, Brown University




Dr. Bradley Allen Maron is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an assistant professor of medicine at Harvard Medical School (HMS). In addition, he serves as a co-director of the Pulmonary Vascular Disease Center at VA Boston Healthcare System.
He received his medical degree from The Warren Alpert Medical School of Brown University and completed an internal medicine residency at Boston Medical Center. He then completed cardiovascular medicine research and clinical fellowship programs at BWH.

Associate Professor
Harvard Medical School
Medicine


VA Boston Healthcare System


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Rhodes CJ, Sweatt AJ, Maron BA. Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension. Circ Res. 2022 Apr 29; 130(9):1423-1444. PMID: 35482840
     
  2. Maron BA, Humbert M. HFp2EF: heart failure with pulmonary dysfunction and preserved ejection fraction? Eur Heart J. 2022 Apr 25. PMID: 35466998
     
  3. Maron BA, Humbert M. Finding Pulmonary Arterial Hypertension-Switching to Offense to Mitigate Disease Burden. JAMA Cardiol. 2022 Apr 01; 7(4):369-370. PMID: 35234810; PMCID: PMC9040384; DOI: 10.1001/jamacardio.2022.0011;
     
  4. Zeder K, Banfi C, Steinrisser-Allex G, Maron BA, Humbert M, Lewis GD, Berghold A, Olschewski H, Kovacs G. Diagnostic, prognostic and differential-diagnostic relevance of pulmonary hemodynamics during exercise - a systematic review. Eur Respir J. 2022 Mar 24. PMID: 35332069
     
  5. Johnson SW, Gillmeyer KR, Bolton RE, McCullough MB, Qian SX, Maron BA, Klings ES, Wiener RS. Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy. Ann Am Thorac Soc. 2022 Mar 21.View Related Profiles. PMID: 35312466
     
  6. Maron BA, Choudhary G, Goldstein RL, Garshick E, Jankowich M, Tucker TJS, LaCerda KA, Hattler B, Dempsey EC, Sadikot RT, Shapiro S, Rounds SI, Goldstein RH. Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial. Pulm Circ. 2022 Jan; 12(1):e12043.View Related Profiles. PMID: 35506072; PMCID: PMC9053004; DOI: 10.1002/pul2.12043;
     
  7. Johnson SW, Maron BA. COUNTERPOINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? No. Chest. 2022 02; 161(2):313-315.View Related Profiles. PMID: 35131055
     
  8. Johnson SW, Maron BA. Rebuttal From Drs Johnson and Maron. Chest. 2022 02; 161(2):316-317.View Related Profiles. PMID: 35131057
     
  9. Kovacs G, Maron BA. The assessment of pulmonary arterial pressure and its clinical relevance: a 100-year journey from Europe, over the United States to Australia. Eur Respir J. 2022 01; 59(1). PMID: 34972686
     
  10. Gong J, Castro RRT, Caron JP, Bay CP, Hainer J, Opotowsky AR, Mehra MR, Maron BA, Di Carli MF, Groarke JD, Nohria A. Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum. ESC Heart Fail. 2022 02; 9(1):293-302. PMID: 34931762; PMCID: PMC8788025; DOI: 10.1002/ehf2.13761;
     
Showing 10 of 159 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 159 publications over 18 distinct years, with a maximum of 28 publications in 2020

YearPublications
20051
20061
20075
20082
20093
20103
20111
20127
201310
20147
20156
201615
201713
201814
201915
202028
202120
20228

Contact for Mentoring:
Maron's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department